Multiple 100 Hz electroacupuncture treatments produced cumulative effect on the suppression of morphine withdrawal syndrome: Central preprodynorphin mRNA and p-CREB implicated

Peptides

Volumn 32, Issue 4, 2011, Pages 713-721

  Wang, Gui Bin ^a   Wu, Liu Zhen ^a   Yu, Peng ^a   Li, Yi Jing ^a   Ping, Xing Jie ^a   Cui, Cai Lian ^a  

^a NONE

Author keywords

Electroacupuncture; Morphine dependence; p CREB; Preprodynorphin; Preproenkephalin; Withdrawal

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DYNORPHIN; MESSENGER RNA; MORPHINE; PREPRODYNORPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; ELECTROACUPUNCTURE; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SPINAL CORD; WITHDRAWAL SYNDROME;

ANIMALS; BASE SEQUENCE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA PRIMERS; DYNORPHINS; ELECTROACUPUNCTURE; MALE; MORPHINE; PHOSPHORYLATION; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

RATTUS;

EID: 79952817966     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.12.006     Document Type: Article

References (49)

1. Aceto MD, Bowman ER.Blockade of dynorphin A(1-13) overt psychomotor effects by naloxone. Peptides 1992;13:847-9.
2. Akbarian S, Rios M, Liu RJ, Gold SJ, Fong HF, Zeiler S, et al. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J Neurosci 2002;22:4153-62. (Pubitemid 37465722)
3. Amato L, Davoli M, Minozzi S, Ali R, Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev 2005:CD003409.
4. Brandao ML. Involvement of opioid mechanisms in the dorsal periaqueductal gray in drug abuse. Rev Neurosci 1993;4:397-405. (Pubitemid 24031181)
5. Burke MC, Letts PA, Krajewski SJ, Rance NE. Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: morphologic evidence of interrelated function within the arcuate nucleus. J Comp Neurol 2006;498:712-26. (Pubitemid 44350359)
6. Cao JL, He JH, Ding HL, Zeng YM. Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. Pain 2005;118:336-49.
7. Carlezon Jr WA, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005;28:436-45. (Pubitemid 40982557)
8. Carlezon Jr WA, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, et al. Regulation of cocaine reward by CREB. Science 1998;282:2272-5. (Pubitemid 29004079)
9. Castilho VM, Borelli KG, Brandao ML, Nobre MJ. Anxiety-like symptoms induced by morphine withdrawalmaybe due to the sensitization of the dorsal periaqueductal grey. Physiol Behav 2008;94:552-62. (Pubitemid 351834747)
10. Chen X, Geller EB, Rogers TJ, Adler MW. The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats. Brain Res 2007;1153:52-7. (Pubitemid 46802539)
11. Cole RL, Konradi C, Douglass J, Hyman SE. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 1995;14:813-23.
12. Cui CL, Wu LZ, Luo F. Acupuncture for the treatment of drug addiction. Neurochem Res 2008;33:2013-22.
13. Cui X. Expression and localization of immediate early genes and preproenkephalin gene in gentral nervous system following fletroacupuncture stimulation. Progr Phys Sci 1995;3:230-2.
14. Desjardins S, Belkai E, Crete D, Cordonnier L, Scherrmann JM, Noble F, et al. Effects of chronic morphine and morphine withdrawal on gene expression in rat peripheral blood mononuclear cells. Neuropharmacology 2008;55:1347-54.
15. Douglass J, McKinzie AA, Pollock KM. Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol Endocrinol 1994;8:333-44. (Pubitemid 24108361)
16. Espinosa VP, Liu Y, Ferrini M, Anghel A, Nie Y, Tripathi PV, et al. Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the switch to opiate addiction. Neuroscience 2008;156:788-99.
17. Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. CREB: a major mediator of neuronal neurotrophin responses. Neuron 1997;19:1031-47. (Pubitemid 27512364)
18. Fukunaga Y, Kishioka S. Enkephalinergic neurons in the periaqueductal gray and morphine withdrawal. Jpn J Pharmacol 2000;82:175-80. (Pubitemid 30209524)
19. Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother 2004;5:713-25. (Pubitemid 38489498)
20. Gowing L, Farrell M, Ali R, White JM. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 2009:CD002024.
21. Green PG, Lee NM, Dynorphin. A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration. Eur J Pharmacol 1988;145:267-72. (Pubitemid 18018846)
22. Guo HF, Wang XM, Tian JH, Huo YP, Han JS. 2Hz and 100 Hz electroacupuncture accelerate the expression of genes encoding three opioid peptides in the rat brain. Sheng Li Xue Bao 1997;49:121-7.
23. Han JS, Zhang RL. Suppression of morphine abstinence syndrome by body electroacupuncture of different frequencies in rats. Drug Alcohol Depend 1993;31:169-75. (Pubitemid 23066507)
24. Han JS, Wu LZ, Cui CL. Heroin addicts treated with transcutaneous electrical nerve stimulation of identified frequencies. Regulatory Peptides 1994;54:115-6. (Pubitemid 24360357)
25. Han JS. Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 2003;26:17-22.
26. Hooke LP, He L, Lee NM, Dynorphin. A modulates acute and chronic opioid effects. J Pharmacol Exp Ther 1995;273:292-7.
27. Iremonger KJ, Bains JS. Retrograde opioid signaling regulates glutamatergic transmission in the hypothalamus. J Neurosci 2009;29:7349-58.
28. Klein G, Juni A, Arout CA, Waxman AR, Inturrisi CE, Kest B. Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors. Eur J Pharmacol 2008;586:179-88.
29. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, et al. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 1997;17:7890-901. (Pubitemid 27426226)
30. Laschka E, Teschemacher H, Mehraein P, Herz A. Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas. Psychopharmacologia 1976;46:141-7.
31. Leal MB,Michelin K, Souza DO, Elisabetsky E. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-d-aspartate receptors. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:781-5. (Pubitemid 36969805)
32. Li SX, Liu LJ, Jiang WG, Lu L. Morphine withdrawal produces circadian rhythm alterations of clock genes in mesolimbic brain areas and peripheral blood mononuclear cells in rats. J Neurochem 2009;109:1668-79.
33. Lightman SL, Young 3rd WS. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortinmRNAresponses to stress and opiates in the rat. J Physiol 1988;403:511-23.
34. Liu HF, Zhou WH, Xie XH, Cao JL, Gu J, Yang GD. Muscarinic receptors modulate the mRNA expression of NMDA receptors in brainstem and the release of glutamate in periaqueductal grey during morphine withdrawal in rats. Sheng Li Xue Bao 2004;56:95-100.
35. Liu TT, Shi J, Epstein DH, Bao YP, Lu L. A meta-analysis of Chinese herbal medicine in treatment of managed withdrawal from heroin. Cell Mol Neurobiol 2009;29:17-25.
36. Maldonado R, Fournie-Zaluski MC, Roques BP. Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter. Naunyn Schmiedebergs Arch Pharmacol 1992;345:466-72.
37. Massardier D, Hunt PF. A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-d-aspartate (NMDA) receptor. Eur J Pharmacol 1989;170:125-6.
38. Miletic G, Hanson EN, Savagian CA, Miletic V. Protein kinase A contributes to sciatic ligation-associated early activation of cyclic AMP response element binding protein in the rat spinal dorsal horn. Neurosci Lett 2004;360: 149-52. (Pubitemid 38479755)
39. Misra K, Pandey SC. The decreased cyclic-AMP dependent-protein kinase A function in the nucleus accumbens: a role in alcohol drinking but not in anxiety-like behaviors in rats. Neuropsychopharmacology 2006;31:1406-19.
40. Nieto MM, Wilson J, Cupo A, Roques BP, Noble F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J Neurosci 2002;22:1034-41. (Pubitemid 34141783)
41. Popik P, Skolnick P, The. NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol Biochem Behav 1996;53:791-7.
42. Punch LJ, Self DW, Nestler EJ, Taylor JR. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci 1997;17:8520-7. (Pubitemid 27461073)
43. Shi XD, Wang GB, Ma YY, Ren W, Luo F, Cui CL, et al. Repeated peripheral electrical stimulations suppress both morphine-induced CPP and reinstatement of extinguished CPP in rats: accelerated expression of PPE and PPD mRNA in NAc implicated. Brain Res Mol Brain Res 2004;130:124-33. (Pubitemid 39440743)
44. Takemori AE, Loh HH, Lee NM. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur J Pharmacol 1992;221:223-6.
45. Takemori AE, Loh HH, Lee NM. Suppression by dynorphin A and [des-Tyr1] dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice. J Pharmacol Exp Ther 1993;266:121-4. (Pubitemid 23315636)
46. Wen HL, Ho WK. Suppression of withdrawal symptoms by dynorphin in heroin addicts. Eur J Pharmacol 1982;82:183-6. (Pubitemid 12019265)
47. Wu LZ, Cui CL, Tian JB, Ji D, Han JS. Suppression of morphine withdrawal by electroacupuncture in rats: dynorphin and kappa-opioid receptor implicated. Brain Res 1999;851:290-6. (Pubitemid 30038161)
48. Zachariou V, Liu R, LaPlant Q, Xiao G, Renthal W, Chan GC, et al. Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies. Biol Psychiatry 2008;63:1013-21.
49. Zhang H, Pandey SC. Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal. Peptides 2003;24:1397-402. (Pubitemid 38045547)